Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 326 - 350 of 6046 in total
Sub Class ▲ LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Diacylglycerophosphoinositolglycans LMGP15010128
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/14:0)
126457496 1310.699958 C60H111O28P
Diacylglycerophosphoinositolglycans LMGP15010129
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/16:0)
126457497 1338.731258 C62H115O28P
Diacylglycerophosphoinositolglycans LMGP15010130
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/16:1(9Z))
126457498 1336.715608 C62H113O28P
Diacylglycerophosphoinositolglycans LMGP15010131
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/16:2(9Z,12Z))
126457499 1334.699958 C62H111O28P
Diacylglycerophosphoinositolglycans LMGP15010132
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/18:0)
126457500 1366.762558 C64H119O28P
Diacylglycerophosphoinositolglycans LMGP15010133
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/18:1(9Z))
126457501 1364.746908 C64H117O28P
Diacylglycerophosphoinositolglycans LMGP15010134
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:1(9Z)/14:0)
126457502 1308.684308 C60H109O28P
Diacylglycerophosphoinositolglycans LMGP15010135
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:1(9Z)/16:0)
126457503 1336.715608 C62H113O28P
Diacylglycerophosphoinositolglycans LMGP15010136
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:1(9Z)/16:1(9Z))
126457504 1334.699958 C62H111O28P
Diacylglycerophosphoinositolglycans LMGP15010137
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:1(9Z)/16:2(9Z,12Z))
126457505 1332.684308 C62H109O28P
Diacylglycerophosphoinositolglycans LMGP15010138
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:1(9Z)/18:0)
126457506 1364.746908 C64H117O28P
Diacylglycerophosphoinositolglycans LMGP15010139
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:1(9Z)/18:1(9Z))
126457507 1362.731258 C64H115O28P
Diacylglycerophosphoinositolglycans LMGP15010140
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:2(9Z,12Z)/14:0)
126457508 1306.668658 C60H107O28P
Diacylglycerophosphoinositolglycans LMGP15010141
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:2(9Z,12Z)/16:0)
126457509 1334.699958 C62H111O28P
Diacylglycerophosphoinositolglycans LMGP15010142
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:2(9Z,12Z)/16:1(9Z))
126457510 1332.684308 C62H109O28P
Diacylglycerophosphoinositolglycans LMGP15010143
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:2(9Z,12Z)/16:2(9Z,12Z))
126457511 1330.668658 C62H107O28P
Diacylglycerophosphoinositolglycans LMGP15010144
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:2(9Z,12Z)/18:0)
126457512 1362.731258 C64H115O28P
Diacylglycerophosphoinositolglycans LMGP15010145
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:2(9Z,12Z)/18:1(9Z))
126457513 1360.715608 C64H113O28P
Diacylglycerophosphoinositolglycans LMGP15010146
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(16:0/14:0)
126457514 1430.705833 C63H115O33P
Diacylglycerophosphoinositolglycans LMGP15010147
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(16:0/16:0)
126457515 1458.737133 C65H119O33P
Diacylglycerophosphoinositolglycans LMGP15010148
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(16:0/16:1(9Z))
126457516 1456.721483 C65H117O33P
Diacylglycerophosphoinositolglycans LMGP15010149
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(16:0/16:2(9Z,12Z))
126457517 1454.705833 C65H115O33P
Diacylglycerophosphoinositolglycans LMGP15010150
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(16:0/18:0)
126457518 1486.768433 C67H123O33P
Diacylglycerophosphoinositolglycans LMGP15010151
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(16:0/18:1(9Z))
126457519 1484.752783 C67H121O33P
Diacylglycerophosphoinositolglycans LMGP15010152
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(17:0/14:0)
126457520 1444.721483 C64H117O33P

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024